Search
for
Sort by
Research 871–900 of 1000+
- Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil
- New Modalities in the Treatment of Refractory Alopecia Areata
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A systematic review
- Association Between Interleukin 18 Polymorphisms and Alopecia Areata in Koreans
- Three Cases of Alopecia Following Clinical Islet Transplantation
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- Endogenous Retinoids in the Pathogenesis of Alopecia Areata
- Paxbp1 is Indispensable for the Maintenance of Hair Follicle Homeostasis
- Combination Therapy With CGF and Microneedling‐Assisted Compound Betamethasone for Resistant Alopecia Areata: APilot Study
- Recurrent pseudolymphomatous reaction to ear piercing: 20-year history
- Vaccines, adjuvants and autoimmunity
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- The Potential Relevance of the Microbiome to Hair Physiology and Regeneration: The Emerging Role of Metagenomics
- Evaluation of association of vitamin D in alopecia areata: A case–control study of 100 patients in a tertiary rural hospital of Southern India
- Janus kinase inhibitors for alopecia areata: A narrative review
- Prognostic Factors in Mexican Patients with Patchy and Other Types of Alopecia Areata
- Post-marketing safety profile of cladribine in multiple sclerosis: a disproportionality analysis based on the FDA adverse event reporting system
- Perinevoid Alopecia: Report of Two Cases and Literature Review
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital